Genprex Inc GNPX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 4:00 PM EDT
2.45quote price arrow down-0.05 (-2.20%)
Volume
43,392
52 week range
2.09 - 42.40
Loading...
  • Open2.48
  • Day High2.64
  • Day Low2.34
  • Prev Close2.50
  • 52 Week High42.40
  • 52 Week High Date06/02/23
  • 52 Week Low2.09
  • 52 Week Low Date04/26/24

Key Stats

  • Market Cap5.142M
  • Shares Out2.10M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.59
  • YTD % Change-73.7

KEY STATS

  • Open2.48
  • Day High2.64
  • Day Low2.34
  • Prev Close2.50
  • 52 Week High42.40
  • 52 Week High Date06/02/23
  • 52 Week Low2.09
  • 52 Week Low Date04/26/24
  • Market Cap5.142M
  • Shares Out2.10M
  • 10 Day Average Volume0.05M
  • Dividend-
  • Dividend Yield-
  • Beta-0.59
  • YTD % Change-73.7

RATIOS/PROFITABILITY

  • EPS (TTM)-22.93
  • P/E (TTM)-0.11
  • Fwd P/E (NTM)-0.37
  • EBITDA (TTM)-31.065M
  • ROE (TTM)-207.88%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date08/21/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Genprex Inc

 

Profile

MORE
Genprex, Inc. is a clinical-stage gene therapy company focused on developing therapies for patients with cancer and diabetes. The Company’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, who have limited treatment options. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System which encapsulates the gene-expressing plasmids using lipid nanoparticles. The...
Jose Moreno Toscano
Independent Chairman of the Board
Ryan Confer
President, Chief Executive Officer, Chief Financial Officer, Director
Hemant Kumar Ph.D.
Chief Manufacturing and Technology Officer
Catherine Vaczy Esq., J.D.
Executive Vice President, General Counsel, Chief Strategy Officer
Address
1601 Trinity Street
Bldg. B, Suite 3.322
Austin, TX
78712
United States

Top Peers

SYMBOLLASTCHG%CHG
COEP
Coeptis Therapeutics Holdings Inc
0.3553+0.0003+0.0845%
IMNN
Imunon Inc
1.40-0.01-0.71%
OTLC
Oncotelic Therapeutics Inc
0.0375+0.0015+4.1667%
ONVO
Organovo Holdings Inc
1.04+0.01+0.97%
NCNA
NuCana PLC
3.70-0.08-2.12%